ArticleBMC endocrine disorders2022

Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma.

Hodaka Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.